Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-12-12 12:44 Tx date 2023-12-08 |
$BETR
BetterLife Pharma Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-60,000 vol |
200,000 | |
Filed 2023-02-08 14:25 Tx date 2020-06-29 |
$BETR
BetterLife Pharma Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-328,500 vol |
36,500 | |
Filed 2023-01-18 12:54 Tx date 2023-01-13 |
$BETR
BetterLife Pharma Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
260,000 | |
Filed 2022-03-04 17:49 Tx date 2022-03-01 |
$BETR
BetterLife Pharma Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
160,000 | |
Filed 2022-03-04 17:48 Tx date 2021-12-14 |
$BETR
BetterLife Pharma Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-200,000 vol |
60,000 | |
Filed 2020-12-17 18:30 Tx date 2020-12-14 |
$BETR
BetterLife Pharma Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-200,000
-200,000 vol $1.00 each |
260,000 | |
Filed 2020-12-17 18:29 Tx date 2020-12-09 |
$BETR
BetterLife Pharma Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,200
+60,000 vol $0.77 each |
460,000 | |
Filed 2020-12-17 18:28 Tx date 2020-06-29 |
$BETR
BetterLife Pharma Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-3,600,000 vol |
400,000 | |
Filed 2019-11-15 15:23 Tx date 2019-11-12 |
$PVOT
Pivot Pharmaceuticals Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+165,000 vol |
365,000 | |
Filed 2019-03-25 Tx date 2019-03-25 |
$PVOT
Pivot Pharmaceuticals Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$30,000
+200,000 vol $0.15 each |
200,000 | |
Filed 2019-03-25 Tx date 2015-02-05 |
$PVOT
Pivot Pharmaceuticals Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-12-14 Tx date 2015-12-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+2,000,000 vol $0.10 each |
2,000,000 | |
Filed 2017-12-14 Tx date 2016-12-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+2,000,000 vol $0.10 each |
4,000,000 | |
Filed 2017-12-14 Tx date 2015-02-05 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|